Mobile Application for Improving Symptoms and Adherence to Oral Chemotherapy in Patients With Cancer

NACompletedINTERVENTIONAL
Enrollment

212

Participants

Timeline

Start Date

February 18, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Adherence to Medication RegimeCancer
Interventions
OTHER

Mobile Application Intervention

Participants assigned to the intervention group will receive the mobile application intervention for approximately three months after enrollment. The mobile app intervention will consist of completing an initial chemotherapy treatment plan, responding to weekly assessments regarding symptoms, side effects, and medication adherence, as well as receiving personalized feedback about responses. The results from patient surveys within the app will also be transmitted in real-time to the participants' oncology clinicians via a HIPAA-compliant, secure email.

Trial Locations (3)

01923

Massachusetts General Hospital/North Shore Cancer Center, Boston

02114

Massachusetts General Hospital, Boston

01742

Massachusetts General Hospital At Emerson Hospital-Bethke, Concord

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT02157519 - Mobile Application for Improving Symptoms and Adherence to Oral Chemotherapy in Patients With Cancer | Biotech Hunter | Biotech Hunter